GlycoMimetics Inc (NASDAQ: GLYC) has experienced a rise in its stock price by 6.05 compared to its previous closing price of 2.15. However, the company
The 36-month beta value for GLYC is at 2.20. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 2
Company’s 36-month beta value is 2.20.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as
GlycoMimetics Inc (NASDAQ: GLYC) has experienced a rise in its stock price by 11.58 compared to its previous closing price of 2.85. However, the company
GlycoMimetics Inc (NASDAQ: GLYC)’s stock price has gone decline by -5.57 in comparison to its previous close of 3.05, however, the company has experienced a
© 2024, Fueled by Smart TechOne
